Abstract-This study aims to employ in vivo dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate the ocular transport following an induction of ocular hypertension in a rat model of chronic glaucoma. Upon systemic administration of Gd-DTPA solution, T1-weighted signal increase was observed in the vitreous body of the glaucomatous eye but not the control eye. This increase occurred earlier in the anterior vitreous body than the preretinal vitreous. Further, there was an earlier Gd-DTPA transport into the anterior chamber in the majority of glaucomatous eyes. Our DCE-MRI findings revealed the leakage of Gd-DTPA at the aqueous-vitreous interface, which was likely resulted from increased permeability of blood-aqueous or aqueous-vitreous barrier. These may explain the sources of changing biochemical compositions in the chamber components, which may implicate the neurodegenerative processes in the glaucomatous visual components.
across epithelial cells lining the surface of the ciliary processes [6] , and is drained away from the venous plexus of the limbus via a circumferential Schlemm's canal into multiple radial veins located within the episclera [2] . This conventional route of aqueous humor outflow [7] taken by plasma-derived proteins has been traced using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) [8] , by demonstrating the entrance of an exogenous MR contrast agent Gd-DTPA from the bloodstream into the ciliary body stroma, and its exit via the iris root [9] . This potentiated the study of changes in aqueous flow in the rat model of chronic glaucoma using DCE-MRI.
Despite the relatively small molecular mass of Gd-DTPA (938 Da), in normal intact eyes, the blood-retinal barrier and aqueous-vitreous barrier are impermeable to Gd-DTPA [10, 11] . DCE-MRI has been used to examine the pathology that altered the permeability of blood-aqueous barrier [9, 12] and blood-retinal barrier [11, 13] in both human and animal eyes. On the basis of the previous findings about the potential roles of blood-ocular [14] [15] [16] and aqueous-vitreous barrier integrity [17] [18] [19] in the pathogenesis of POAG, this study aims to employ high resolution DCE-MRI to understand the aqueous humor dynamics following an induction of ocular hypertension in a rat model of chronic glaucoma. We hypothesized that systemic administration of Gd-DTPA into our glaucoma model would detect whether leakage existed at the aqueous-vitreous interface giving rise to a progressive signal enhancement in the anterior vitreous body of the glaucomatous eye. Further, we attempted to monitor the transport of Gd-DTPA into the anterior chamber of our glaucoma model. Such transport phenomena may help understand the sources of biochemicals present in the chamber components of the glaucomatous eye, which may have participated in the neurodegenerative processes in the retina and the optic nerve [20, 21] .
II. MATERIALS AND METHODS

A. Animal Preparation
Sprague-Dawley female rats (250-280 g, 3 months old, N=11) were divided into two groups and were induced for ocular hypertension unilaterally in the right eye by photocoagulation of episcleral veins and the limbal veins on the surface of the eyeball using an argon laser. DCE al [22] and has been adopted in our laboratory for the study of retinal degeneration and therapeutic effects on retinal functions [20, 21, 23, 24] . After each procedure, antibiotic ointment was applied topically to the eye surface.
B. MRI Protocols
All MRI measurements were acquired on a 7T Bruker scanner using a birdcage transmit-only RF coil in combination with an actively decoupled receive-only quadrature surface coil. Under inhaled isoflurane anaesthesia (3% induction and 1.5% maintenance), the animal was kept warm under circulating water at 37 o C. A saline phantom was inserted beside the rat for signal intensity normalization during post-processing. Five days (Group 1) and 8 weeks (Group 2) after laser treatment, Gd-DTPA (Magnevist) was applied intraperitoneally at 3 mmol/kg, and 2D fast spin echo (FSE) T1-weighted imaging (T1WI) was acquired with fat suppression, TR/TE = 320/8.9 ms, echo train length = 4, NEX = 26, slice thickness = 1 mm, FOV = 3.2 x 3.2 cm 2 and voxel resolution = 82.3 x 82.3 µm 2 . Acquisition time was 10 minutes for each time point, and T1WI was applied before and 10 to 80 minutes after injection. Throughout the experiments, the left eye served as a control. Between 0 and 10 minutes after injection, T1WI was also acquired in Group 1 with the same T1WI protocol above but with NEX = 5 and acquisition time = 2 min for each time point to monitor the enhanced pattern immediately after injection. Fig. 1 . Illustration of the typical ROI definitions of the anterior chamber (AC) and vitreous body (VB) to quantify the DCE-MRI measurements. The lens (Ln) and optic nerves (ON) could be observed as hypointense signals in both pre-(left) and post-(right) systemic Gd-DTPA injection images, while the hyperintense ciliary processes could be found between the posterior chamber (PC) and VB after systemic Gd-DTPA injection (right).
C. Data Analysis
In the 2D slice that centrally cut through the eyeball and optic nerve head, regions of interest (ROIs) were drawn manually on the whole anterior chamber, and on the vitreous body covering a distance of 3.5 mm on each side from the optic nerve head using ImageJ v1.38 (Wayne Rasband, NIH, USA) as shown in Figure 1 . Each value was calibrated to the nearby phantom containing saline solution to avoid the effect of any MRI system sensitivity drift. A quantitative measure of the Gd-DTPA entry was obtained from the enhancement in the MR signal intensity defined as E = [S(t) -S o ]/S o , where S(t) is the calibrated spin-echo signal intensity of the ROIs, and S o is the T1-weighted signal intensity of the same ROI before the MR tracer injection. Differences between mean values of the ROIs on both sides were compared using two-tailed paired t-tests, and the mean values along the time course were compared using ANOVA. Results were considered to be significantly different when p<0.05.
III. RESULTS Fig. 2 . Serial T1-weighted images (T1WIs) of a rat at Day 5 (Group 1) after glaucoma induction. Images were acquired within the first 10 minutes following systemic Gd-DTPA administration. Note that in 3 out of the 5 rats in the group, the intensity in the anterior chamber was greater for the glaucomatous eye (R) (arrow) than the control one (L) in the first 10 minutes after systemic Gd-DTPA administration. Figures 2 and 3 show the serial T1WIs of the glaucomatous and control eyes after systemic Gd-DTPA administration. Figure 4 shows the mean percent signal enhancement, E, as a function of the time for the vitreous body in both eyes. In the control eye, there was an immediate enhancement of the ciliary processes, iris and chorioretina in all scanned rats after Gd-DTPA administration (Figure 2) . The anterior chamber enhanced substantially over the first 40-60 minutes after Gd-DTPA administration (ANOVA, p<0.01), while the vitreous and lens did not enhance at any time (ANOVA, p>0.05) (Figure 3 ). These patterns of T1-weighted signal enhancements generally followed as previously described [8] [9] [10] 25 ] and were of consistent or better spatial and temporal resolutions.
Similar patterns appeared in the glaucomatous eye. However, the vitreous body enhanced progressively from 10 minutes post-administration in both groups after glaucoma induction ( Figures 3 and 4) (ANOVA, p<0.01). Significant difference was observed between the glaucomatous and the control eyes in Group 2 (paired t-test, p<0.05), and was marginally observed in Group 1 (paired t-test, p <0.07 for the later 2 time points). No apparent difference was observed between the two groups on the signal changes in the glaucomatous eyes (unpaired t-test, p>0.05). Qualitative inspection of the MR images of both groups suggested that Gd-DTPA leaked at the aqueous-vitreous interface and diffused into the vitreous body from the anterior parts of the glaucomatous eye in all rats, while no apparent signal increase was observed in the same location in the control eyes ( Figure 3 ). Note that in 3 out of the 5 rats in Group 1, the intensity in the anterior chamber is greater for the glaucomatous eye than the control one in the first 10 minutes after Gd-DTPA administration (Figure 2 ). For Group 2, 4 out of 6 rats had their signal intensities higher in the glaucomatous anterior chamber than the control throughout the experiment. 
IV. DISCUSSIONS
In the present study we characterized the aqueous humor dynamics in a rat model of chronic glaucoma. Obstruction of aqueous humor outflow is the primary mechanism of pressure elevation in the current glaucoma model [26] analogous to the pathogenesis of human POAG [27] . Our DCE-MRI results showed an alteration of the typical aqueous outflow in the glaucomatous eye that might explain the changing biochemical compositions in the anterior chamber and vitreous body [15, 16, 19] .
The aqueous humor proteins have been identified as suspected participants in the obstruction of the aqueous humor outflow network from the eye resulting in elevated IOP in POAG [27] . Protein concentration in the anterior chamber of normal eyes has been identified to be determined by the rate of protein entry into the aqueous humor, the removal rate by bulk flow of aqueous humor, and the anterior chamber volume [28] . Our results of increased Gd-DTPA level in the anterior chamber appeared to correlate with the breakdown of blood-aqueous barrier in various glaucoma which resulted in an increase in the aqueous protein level upon the presence of cytokines and other inflammatory mediators in the aqueous humor [9, 12] including vascular endothelial growth factor [16] and endothelin-1 [15] .
On the other hand, the earlier T1-weighted signal increase in the anterior vitreous body indicated the leakage of Gd-DTPA at the aqueous-vitreous interface upon aqueous outflow obstruction. A recent study had commented on the impact of IOP on the induction of the hydraulic flow permeating through the vitreous body [18] . When the IOP was increased in the current glaucoma model, it was likely that this anteriorly directed fluid movement across the aqueous-vitreous interface would be reduced [29] . In addition, in response to prolonged IOP elevation, the ciliary epithelium which prevents the aqueous humor proteins from entering the posterior chamber by its tight junctions [27] , has been shown to undergo atrophy in canine [30] . Iris atrophy was also observed in a transgenic glaucoma model [31] . The reduced limitation of back-diffusion of solutes might attribute to the posterior transport of Gd-DTPA from the anterior chamber to the vitreous body. Note that the pattern of leakage of proteins from the blood supply in the ciliary body/iris complex has been postulated in experimental newborn rats, when the tight junctions of the blood-ocular barriers were underdeveloped [32] .
In one of the glaucomatous eyes in Group 2, a faster leakage into the vitreous body was observed compared to the other diseased eyes of the same group, while a prominent lens depression was also noted ( Figure 5 ). Upon perfusion of the anterior chamber at elevated pressures, the iris and the detached portion of the ciliary body were pushed backwards [17] . A significant increase in the number of giant vacuoles was also found in the endothelium of several blood vessels in the rat ciliary body and the iris root [7] . These might also contribute to the compromise of the aqueous-vitreous barrier integrity, allowing Gd-DTPA to pass into the vitreous body. Our results potentially explained the routes for the leakage of serum proteins as well as the release of proteolytic enzymes into the rat vitreous body upon chronic intraocular hypertension [19] . DCE-MRI was also performed at Week 18 on three of the Group 2 animals scanned, and similar pattern of Gd-DTPA leakage was observed as in Groups 1 and 2 (data not shown). No statistical difference was observed in the signal changes in the glaucomatous eyes between two groups, which was in agreement with the fact that a consistent IOP elevation of 1.6 times above normal was maintained in our model across the 8-week experimental period [21] . Further studies may employ multi-compartment modeling for more comprehensive kinetics analyses in the future. 
V. CONCLUSIONS
The results presented here constitute the first report in assessing the leakage at the aqueous-vitreous interface upon ocular hypertension by DCE-MRI. A progressive T1-weighed signal increase was observed in the vitreous body of the glaucomatous eye but not the control eye, while an earlier Gd-DTPA transport was found in the anterior chamber of the glaucomatous eye. The authors demonstrated the values of MRI in providing a means for direct noninvasive visualization of physiological kinetics in the glaucomatous chamber components in vivo.
